IL6 and rheumatoid arthritis: Multiple types of biomarkers are being investigated for the purpose of RA disease activity monitoring: serum acute phase reactants, genetic factors, and tissue-specific markers from cartilage, bone, and synovium. IL-6, a prominent acute phase reactant in RA, remains under investigation but unfortunately has not been found to correlate with the radiographic progression of the disease [59].